Key result
This Ideas and Opinions article highlights growing concerns and reports of serious adverse events and bleeding complications associated with the oral direct thrombin inhibitor dabigatran.
No takes yet. Share an insight, caveat, or question.
This opinion piece highlights emerging post-market safety concerns, including serious bleeding events and deaths, associated with the direct thrombin inhibitor dabigatran.
Ryan P. Radecki (2012) conducted an editorial in Dabigatran-related adverse events. Dabigatran was evaluated. This Ideas and Opinions article highlights growing concerns and reports of serious adverse events and bleeding complications associated with the oral direct thrombin inhibitor dabigatran.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: